Ethic Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.2M Buy
39,769
+2,564
+7% +$978K 0.27% 66
2025
Q1
$16.1M Buy
37,205
+12,806
+52% +$5.54M 0.33% 51
2024
Q4
$9M Buy
24,399
+5,471
+29% +$2.02M 0.18% 112
2024
Q3
$9.82M Sell
18,928
-6,118
-24% -$3.17M 0.25% 75
2024
Q2
$13.6M Buy
25,046
+6,118
+32% +$3.32M 0.32% 60
2024
Q1
$9.82M Sell
18,928
-4,858
-20% -$2.52M 0.25% 75
2023
Q4
$11.2M Buy
23,786
+2,494
+12% +$1.18M 0.33% 53
2023
Q3
$9.27M Buy
21,292
+1,831
+9% +$797K 0.33% 55
2023
Q2
$8.65M Buy
19,461
+701
+4% +$311K 0.32% 60
2023
Q1
$8.63M Buy
18,760
+65
+0.3% +$29.9K 0.35% 52
2022
Q4
$9.59M Buy
18,695
+3,099
+20% +$1.59M 0.52% 30
2022
Q3
$7.08M Buy
15,596
+1,489
+11% +$676K 0.48% 29
2022
Q2
$6.81M Buy
14,107
+2,914
+26% +$1.41M 0.47% 35
2022
Q1
$5.5M Buy
11,193
+1,741
+18% +$855K 0.38% 50
2021
Q4
$4.38M Buy
9,452
+1,654
+21% +$767K 0.34% 66
2021
Q3
$2.91M Buy
7,798
+971
+14% +$362K 0.3% 79
2021
Q2
$2.61M Buy
6,827
+1,784
+35% +$681K 0.32% 71
2021
Q1
$1.81M Buy
5,043
+1,908
+61% +$685K 0.32% 71
2020
Q4
$1.01M Buy
3,135
+465
+17% +$149K 0.27% 91
2020
Q3
$717K Buy
2,670
+492
+23% +$132K 0.27% 95
2020
Q2
$573K Buy
2,178
+607
+39% +$160K 0.33% 77
2020
Q1
$357K Buy
1,571
+232
+17% +$52.7K 0.3% 113
2019
Q4
$404K Buy
+1,339
New +$404K 0.3% 112